Xencor | XNCR - Ebitda





Ebitda 변화 날짜
AbbVie USD 5.37B 1.85B 2025-12
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Amgen USD 5.14B 775M 2025-12
Arrowhead Research USD 57.17M 7.03M 2025-12
AstraZeneca USD 5.67B 1.29B 2026-03
Biogen USD 649.7M 76.5M 2026-03
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Cytokinetics USD -169.32M 19.48M 2026-03
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
J&J USD 8.27B 1.08B 2026-03
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
MacroGenics USD -30.2M 52.15M 2026-03
Merck USD 6.3B 2.09B 2025-12
Novartis USD 6.48B 1.19B 2026-06
Pfizer USD 5.99B 5.23B 2026-03
Regeneron Pharmaceuticals USD 1.2B 718.4M 2025-12
Roche Holding CHF 13.43B 744M 2026-06
Xencor USD -51.05M 55.28M 2025-12